Cargando…
Selective biologics for ulcerative colitis and Crohn’s disease – clinical utility of vedolizumab
Inflammatory bowel disease (IBD) encompasses a cluster of different disease phenotypes which are broadly classified into ulcerative colitis and Crohn’s disease. Disease pathogenesis is driven by abnormal host immune responses to their resident gut microbiome in genetically susceptible individuals. C...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790488/ https://www.ncbi.nlm.nih.gov/pubmed/27022240 http://dx.doi.org/10.2147/BTT.S71679 |